Skip to content

Clinical trials

Completed Phase 1 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 1 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20073
20081
20091
20101
20113
20122
20132
20144
20151
20161
20172
20182
20191
20203
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Boehringer Ingelheim3
Eisai Co., Ltd.2
M.D. Anderson Cancer Center2
AVEO Pharmaceuticals, Inc.1
Arbele Pty Ltd1
Celldex Therapeutics1
Chinese Academy of Medical Sciences1
Dana-Farber Cancer Institute1
Five Prime Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms40
Neoplasms13
Colorectal Neoplasms12
Pancreatic Neoplasms12
Breast Neoplasms10
Stomach Neoplasms9
Colonic Neoplasms7
Head and Neck Neoplasms7
Lung Neoplasms7
Melanoma6

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.